Tumor dormancy therapy in recurrent head and neck cancer

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intraoperative radiation therapy for recurrent head and neck cancer.

Forty-seven patients with recurrent head and neck cancer in a previously irradiated field were treated with surgical resection and intraoperative radiation therapy (IORT). Recurrent disease occurred at a median of 18 months from primary treatment, and was at the primary tumor site in 31 and metastatic to regional lymph nodes in 16. Recurrences were squamous cell carcinomas in 42 and adenoid cys...

متن کامل

SBRT for recurrent head and neck cancer

The management of patients with recurrent head and neck cancers is complex. Concerns over toxicity with re-irradiation have limited its use in the clinical setting. Stereotactic Body Radiation Therapy (SBRT) has emerged as a highly conformal and precise type of radiotherapy and has the advantage of sparing normal tissue. Although SBRT is an attractive treatment modality, its use in the clinic i...

متن کامل

Quality of life in head and neck cancer patients

Quality of life in head and neck cancer patients

متن کامل

Targeted Therapy in Recurrent or Metastatic Head and Neck Carcinoma

Submit Manuscript | http://medcraveonline.com Abbreviations: R/M: Recurrent and/or Metastatic; HNSSC: Head and Neck Squamous Cell Carcinoma; FU: Fluorouracil; PFS: Progression-Free Survival; OS: Overall Survival; EGFR: Epidermal Growth Factor Receptor; TGF-α: Transforming Growth Factor-Alpha; TKI: Tyrosine Kinase Inhibitors; mAb: Monoclonal Antibodies; ACU: Area Under the Concentration; PD 1: P...

متن کامل

Targeted Therapy in Recurrent or Metastatic Head and Neck Carcinoma

Submit Manuscript | http://medcraveonline.com Abbreviations: R/M: Recurrent and/or Metastatic; HNSSC: Head and Neck Squamous Cell Carcinoma; FU: Fluorouracil; PFS: Progression-Free Survival; OS: Overall Survival; EGFR: Epidermal Growth Factor Receptor; TGF-α: Transforming Growth Factor-Alpha; TKI: Tyrosine Kinase Inhibitors; mAb: Monoclonal Antibodies; ACU: Area Under the Concentration; PD 1: P...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY

سال: 2003

ISSN: 1349-581X,1884-474X

DOI: 10.5106/jjshns.13.101